Nu Skin

Q2 FY2026 EarningsQ2 FY26 results missed consensus on the top-line, with revenue of $320.1M coming in 7.3% below the $345.2M expected. Adjusted EPS of $0.20 was in-line with consensus, though GAAP figures were heavily impacted by a $78.9M non-cash impairment and a significant valuation allowance on deferred tax assets, resulting in a GAAP loss of $5.14 per share. Revenue declined 17.1% YoY, driven by broad-based weakness across all Nu Skin reporting segments, particularly in the Americas (-18.1%) and South Korea (-24.8%). Full-year FY26 revenue guidance was lowered to $1.28B–$1.35B, significantly trailing the implied prior market expectations.